4fa1414fcc7b78f9bd6f4983c5e0c6bf

Dr Nick Holliday

Chief Scientific Officer

Nick Holliday has over 25 years’ experience in the molecular pharmacology of receptors and other drug targets, and in leading development of biochemical and cellular assay systems for analytical pharmacology and compound profiling.  His interests in imaging technologies to measure ligand binding and intracellular signalling have involved several collaborations with large pharma and SMEs over the years, most recently spearheading Excellerate’s participation in the EU funded SYNSTAR consortium to develop novel therapeutic approaches for obesity.  He also holds a part-time Associate Professorship at the University of Nottingham, and is a Fellow of the British Pharmacological Society.

Get in touch with the Excellerate team today to speak to one of our of expert scientists

Contact Us
Location
Excellerate Biosciences Ltd
21 The Triangle
NG2 Business Park
Nottingham
NG2 1AE

Company Number: 10228159

VAT Number: GB 248960957

UK BioIndustry Association
UK BioIndustry Association
© 2025, Excellerate Bioscience Ltd. All Rights Reserved.